BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/18/2020 2:20:37 PM | Browse: 846 | Download: 1375
 |
Received |
|
2020-08-05 18:21 |
|
Peer-Review Started |
|
2020-08-05 18:21 |
|
First Decision by Editorial Office Director |
|
2020-09-17 16:29 |
|
Return for Revision |
|
2020-09-17 16:29 |
|
Revised |
|
2020-10-01 02:59 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-16 11:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-19 20:21 |
|
Articles in Press |
|
2020-10-19 20:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-05 11:17 |
|
Publish the Manuscript Online |
|
2020-11-18 14:20 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Chemotherapy rechallenge in metastatic colon cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tejaswini Parlapalle Reddy, Usman Khan, Ethan Alexander Burns and Maen Abdelrahim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maen Abdelrahim, BPharm, MD, PhD, Assistant Professor, Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center. Cockrell Center of Advanced Therapeutics Phase I Program, Houston Methodist Research Institute and Weill Cornell Medical College, 6445 Main ST Fl 24, Houston, TX 77030, United States. mabdelrahim@houstonmethodist.org |
| Key Words |
Metastatic colorectal cancer; Rechallenge therapy; Treatment holiday; Oxaliplatin; Irinotecan; Case report |
| Core Tip |
Despite advances in therapeutic strategies, colorectal cancer (CRC) remains a deadly disease. There are limited options for patients with chemo-refractory mCRC. We present a case of a patient with heavily treated metastatic colorectal cancer (mCRC) that was responsive to oxaliplatin-based rechallenge therapy. Oxaliplatin rechallenge therapy provided this patient with a ten-month survival benefit, marked improvement in his clinical condition, performance status, and quality of life. This case highlights the importance of considering rechallenge therapy in patients with chemo-refractory mCRC. Monitoring for oxaliplatin-associated peripheral sensory neuropathy should be considered for patients who qualify for oxaliplatin rechallenge therapy. |
| Publish Date |
2020-11-18 14:20 |
| Citation |
Reddy TP, Khan U, Burns EA, Abdelrahim M. Chemotherapy rechallenge in metastatic colon cancer: A case report. World J Clin Oncol 2020; 11(11): 959-967 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i11/959.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i11.959 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
